Artelo Biosciences shares jump after a glaucoma study deal to test ART27.13, a new treatment targeting eye pressure in patients.
Importance Rank:
1
Artelo Biosciences shares jump after a glaucoma study deal to test ART27.13, a new treatment targeting eye pressure in patients.